Endurance training-induced changes in the GH-IGF-I axis influence maximal muscle strength in previously untrained men.

Growth Horm IGF Res

Department of Muscle Physiology, Chair of Physiology and Biochemistry, Faculty of Rehabilitation, University School of Physical Education, Al. Jana Pawla II 78, 31-571 Krakow, Poland. Electronic address:

Published: February 2017

Objective: In this study we have determined the effects of 20weeks of endurance running training on the GH-IGF-I axis changes in the context of the skeletal muscle performance and physical capacity level.

Design: Before and after the endurance training program a maximal incremental exercise tests, a 1500m race and a muscle strength measurements were performed and the blood samples were taken to determine both resting as well as end-exercise serum growth hormone (GH), insulin-like growth hormone-I (IGF-I), insulin-like growth hormone binding protein-3 (IGFBP-3) and plasma interleukin-6 (IL-6) concentrations.

Results: 20weeks of endurance running training improved power output generated at the end of the maximal incremental test by 24% (P<0.012), 1500m running time by 13% (P<0.012) and maximal muscle strength by 9% (P<0.02). End-exercise IGF-I/IGFBP-3 ratio was decreased by 22% after the training (P<0.04) and the magnitude of IGF-I/IGFBP-3 ratio decrease (ΔIGF-I/IGFBP-3) was 2.3 times higher after the training (P<0.04). The magnitude of the exercise-induced changes in IGFBP-3 concentration was also significantly higher (P<0.04) and there was a trend toward lower end-exercise IGF-I concentration (P=0.08) after the training. These changes were accompanied by a significantly higher (30%) end-exercise IL-6 concentration (P<0.01) as well as by a 3.4 times higher magnitude of IL-6 increase (P<0.02) after the training. Moreover, there were strong positive correlations between changes in resting serum IGF-I concentration (ΔIGF-I) and IGF-I/IGFBP-3 ratio (ΔIGF-I/IGFBP-3) and changes in muscle strength (ΔMVC) (r=0.95, P=0.0003 and r=0.90, P=0.002, respectively).

Conclusions: The training-induced changes in the components of the GH-IGF-I axis may have additive effects on skeletal muscle performance and physical capacity improvement.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ghir.2016.12.003DOI Listing

Publication Analysis

Top Keywords

gh-igf-i axis
8
muscle strength
8
20weeks endurance
8
endurance running
8
running training
8
maximal incremental
8
growth hormone
8
insulin-like growth
8
endurance
4
endurance training-induced
4

Similar Publications

Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly.

Front Endocrinol (Lausanne)

January 2025

Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wrocław, Poland.

Article Synopsis
  • Acromegaly is marked by increased bone turnover and higher vertebral fracture risk, with sclerostin inhibiting bone formation and playing a role in the OPG/RANK-L system that regulates bone metabolism.
  • The study investigated levels of sclerostin, osteoprotegerin (OPG), and RANK-L in 126 patients with varying acromegaly activity, aiming to explore connections between sclerostin and bone health.
  • Results showed lower sclerostin levels in acromegaly patients compared to controls, with notable differences in OPG levels across groups but no significant changes in RANK-L; a positive correlation was found between sclerostin and OPG in patients with various acromegaly
View Article and Find Full Text PDF

Growth hormone (GH) is the key regulator of insulin-like growth factor I (IGF-I) generation in healthy states. However, portal insulin delivery is also an essential co-player in the regulation of the GH/IGF-I axis by affecting and regulating hepatic GH receptor synthesis, and subsequently altering hepatic GH sensitivity and IGF-I generation. Disease states of GH excess (e.

View Article and Find Full Text PDF
Article Synopsis
  • Growth hormone-releasing hormone (GHRH) is traditionally viewed as a key hormone regulating growth and metabolism through the hypothalamic-pituitary axis, but it's also produced in various peripheral tissues, impacting multiple bodily functions.
  • The presence of GHRH and its receptor (GHRH-R) in the reproductive systems of both males and females suggests important roles in gonadal function and reproductive health.
  • This review will examine the GHRH/GHRH-R axis's significance in reproductive physiology and discuss how understanding this axis could lead to new treatments for reproductive disorders like infertility, endometriosis, and cancers linked to the reproductive system.
View Article and Find Full Text PDF

Unlabelled: Body proportions are the objective parameters of harmonious growth and reflect the interplay of genetic, environmental, metabolic, and hormonal actions. Mutations in the growth hormone receptor gene (GHR) result in severe growth failure. The study of individuals affected with these mutations can inform us about the role of growth peptides in harmonious, proportional growth.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers utilized mice with a specific knockout of the GH gene, observing that both male and female mice lived longer due to the absence of GH.
  • * Findings indicated that GH-deficient mice were lighter, had higher body fat percentages, and experienced significant issues with glucose metabolism while showing altered nutrient utilization linked to their extended lifespan.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!